3D printing stocks are in rally mode following respectable results from industry leader 3D Systems (DDD).
Adjusted earnings of $0.12 per share were almost double what the street expectations were, and I’m sure there some short covering involved in the 19% move higher to top $14.50/share.
In the release, CEO Vyomesh Joshi stated:
“We were pleased with continued strong demand for our healthcare solutions and software as well as increased materials sales into advanced industrial and healthcare applications”
It’s noteworthy that DDD is seeing the greatest revenue driver in the medical applications (including materials and software) space- and this is an established trend.
The 3D printing medical devices market (consisting of 3D printing equipment, materials, and services & software) is poised to grow at a CAGR of 25.3% from 2015 to 2020, and to reach USD 2.13 Billion by 2020 according to MarketsandMarkets.
Future Player in 3D Printing Medical Device Market
This may be a future player in the 3D printing medical applications space that’s as-yet unknown…
Take a look at Amedica Corporation (web site) ticker, AMDA
- Loading stock data...
Amedica is commercializing silicon nitride ceramics as a biomaterial platform.
The AMDA market cap is just $15M with about $19.5M in sales last year for a P/S under 1
The company is the first to 3D print Silicon Nitride for medical applications/joint replacement market.
Amedica is also waiting to hear from the FDA on a Composite Interbody Spinal Device utilizing silicon nitride. A decision from the FDA should be announced within the next two weeks according to this press release in June. Obviously a positive announcement from the FDA should be a strong catalyst for a move higher.
Beyond the pending FDA decision on the company’s interbody spinal device, Amedica Corporation is definitely “one to watch” if you are a 3D printing investor and are looking for a future player in the high-growth medical applications space of 3D printing.
Best wishes for profitable investing!
Disclosure: I am long shares of AMDA. I have not been paid by any person or company for this update.